Does TAFASITAMAB-CXIX Cause Polyneuropathy? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Polyneuropathy have been filed in association with TAFASITAMAB-CXIX. This represents 3.9% of all adverse event reports for TAFASITAMAB-CXIX.
29
Reports of Polyneuropathy with TAFASITAMAB-CXIX
3.9%
of all TAFASITAMAB-CXIX reports
0
Deaths
8
Hospitalizations
How Dangerous Is Polyneuropathy From TAFASITAMAB-CXIX?
Of the 29 reports, 8 (27.6%) required hospitalization.
Is Polyneuropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFASITAMAB-CXIX. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does TAFASITAMAB-CXIX Cause?
Disease progression (218)
Lymphoma (158)
Off label use (126)
Death (53)
Drug ineffective (39)
Blood lactate dehydrogenase increased (34)
Diffuse large b-cell lymphoma (32)
Malignant neoplasm progression (30)
Neutropenia (30)
Covid-19 (28)
What Other Drugs Cause Polyneuropathy?
DEXAMETHASONE (953)
BORTEZOMIB (890)
PACLITAXEL (741)
OXALIPLATIN (691)
CYCLOPHOSPHAMIDE (686)
FLUOROURACIL (525)
TRASTUZUMAB (478)
CARBOPLATIN (463)
DOXORUBICIN (452)
VINCRISTINE (440)
Which TAFASITAMAB-CXIX Alternatives Have Lower Polyneuropathy Risk?
TAFASITAMAB-CXIX vs TAFINLAR
TAFASITAMAB-CXIX vs TAFLUPROST
TAFASITAMAB-CXIX vs TAGRAXOFUSP-ERZS
TAFASITAMAB-CXIX vs TAHOR
TAFASITAMAB-CXIX vs TALAZOPARIB